Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
9.07
-1.68 (-15.63%)
At close: Apr 28, 2026, 4:00 PM EDT
8.90
-0.17 (-1.90%)
Pre-market: Apr 29, 2026, 7:21 AM EDT

Artiva Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-83.87-65.37-28.72-58.79-71.83
Upgrade
Depreciation & Amortization
2.62.432.271.160.25
Upgrade
Other Amortization
---4.08-
Upgrade
Loss (Gain) From Sale of Investments
-1.88-2.34-0.46--
Upgrade
Stock-Based Compensation
6.826.987.056.584.31
Upgrade
Other Operating Activities
-3.60.71-18.55
Upgrade
Change in Accounts Receivable
-1.03-0.51-0.06-0.47
Upgrade
Change in Accounts Payable
-0.760.52-0.410.19-1.24
Upgrade
Change in Unearned Revenue
---26.53-2.4528.97
Upgrade
Change in Other Net Operating Assets
0.34-1.88-0.84-1.556.15
Upgrade
Operating Cash Flow
-76.75-55.03-47.43-50.83-15.3
Upgrade
Capital Expenditures
-2.59-0.64-3.26-6.3-1.72
Upgrade
Investment in Securities
66-119.82-22.72--
Upgrade
Investing Cash Flow
63.41-120.46-25.98-6.3-1.72
Upgrade
Long-Term Debt Repaid
-0.13-0.15---
Upgrade
Net Debt Issued (Repaid)
-0.13-0.15---
Upgrade
Issuance of Common Stock
0.14166.560.010.330.18
Upgrade
Repurchase of Common Stock
-0.23--0.01-0.01-
Upgrade
Other Financing Activities
0.23-4.1824.39-1.59-2.03
Upgrade
Financing Cash Flow
0.01162.2324.39-1.26152.75
Upgrade
Net Cash Flow
-13.33-13.27-49.01-58.39135.73
Upgrade
Free Cash Flow
-79.34-55.67-50.69-57.13-17.03
Upgrade
Free Cash Flow Margin
--22180.88%-151.34%-1158.55%-850.55%
Upgrade
Free Cash Flow Per Share
-3.25-4.95-63.14-74.51-24.83
Upgrade
Cash Income Tax Paid
--0.08--
Upgrade
Levered Free Cash Flow
-49.24-33.75-27.32-29.38-17.6
Upgrade
Unlevered Free Cash Flow
-49.24-33.75-27.32-29.38-17.6
Upgrade
Change in Working Capital
-0.42-0.33-28.28-3.8733.41
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.